Diabetes Drugs Study Notes
Objectives
At the end of this chapter, you will be able to:
Discuss the normal functions of the pancreas, including its dual role as both an exocrine and endocrine organ, and how it regulates blood sugar through insulin and glucagon production.
Contrast age of onset, signs and symptoms, pharmacologic and nonpharmacologic treatment, incidence, and cause of type I and type 2 diabetes mellitus, highlighting their unique pathophysiology and management strategies.
Differentiate gestational diabetes from type I and type 2 diabetes mellitus by discussing the hormonal changes during pregnancy and their impact on glucose metabolism.
Discuss the various factors influencing blood glucose levels in nondiabetic individuals and in patients with diabetes mellitus, including dietary choices, physical activity, stress, illness, and medications.
Identify the various drugs used to manage type I and type 2 diabetes mellitus, detailing their classifications, mechanisms of action, and roles in diabetes management.
Discuss the mechanisms of action, indications, contraindications, cautions, drug interactions, and adverse effects of parenteral insulin and oral hypoglycemic drugs to ensure safe and effective use.
Compare rapid-, short-, intermediate-, and long-acting insulins with regard to their onset of action, peak effects, and duration of action, making connections to patient needs and dosing regimens.
Compare the signs and symptoms of hypoglycemia and hyperglycemia and their related treatments, emphasizing the importance of patient education and timely intervention.
Develop a nursing care plan that includes all phases of the nursing process for patients with type I and/or type 2 diabetes, focusing on drug therapies and lifestyle modifications to achieve optimal glycemic control.
Key Terms
Diabetes mellitus: A complex disorder of carbohydrate, fat, and protein metabolism resulting from a lack of insulin secretion by the beta cells of the pancreas or from defects in the insulin receptors; includes two primary forms: type I and type 2 diabetes.
Diabetic ketoacidosis (DKA): A severe metabolic complication of uncontrolled diabetes characterized by hyperglycemia, ketonemia, and metabolic acidosis which can lead to diabetic coma and death if untreated. Prompt identification and management are crucial.
Gestational diabetes: Diabetes that develops during pregnancy, typically arising due to insulin resistance, often resolving after delivery but indicating a heightened risk for developing type 2 diabetes later in life for both the mother and child.
Glucagon: A hormone produced by the alpha cells of the pancreas that plays a vital role in glucose homeostasis by stimulating glycogen breakdown and gluconeogenesis in the liver, thus increasing blood glucose levels during fasting.
Glucose: A major source of energy for the body's cells, primarily derived from dietary carbohydrates, and is crucial for metabolic processes.
Glycogen: The stored form of glucose in the liver and muscle tissues designed for energy reserve.
Glycogenolysis: The biochemical process of converting glycogen back to glucose, mobilizing energy when blood sugar levels drop.
Hemoglobin A1C (A1C): A biomarker indicating average blood glucose levels over the past two to three months. A higher A1C percentage correlates with poor glycemic control in diabetic patients.
Hyperglycemia: Elevated blood glucose levels frequently indicating inadequate diabetes management; defined as a fasting glucose of 126 mg/dL or higher and a nonfasting glucose of 200 mg/dL or higher.
Hyperosmolar hyperglycemic syndrome (HHS): A serious metabolic complication associated with uncontrolled type 2 diabetes characterized by severe hyperglycemia, dehydration, and hyperosmolarity, often without significant ketone production.
Hypoglycemia: An abnormally low blood glucose level, often resulting from excessive insulin or inadequate carbohydrate intake, which can lead to confusion, seizures, or loss of consciousness if not treated promptly.
Insulin: A peptide hormone secreted by the pancreas that facilitates cellular glucose uptake and utilization, crucial for maintaining normal blood glucose levels.
Ketones: Organic compounds produced from fat metabolism during insulin deficiency, signifying the body’s shift to using fat for energy in absence of sufficient glucose.
Polydipsia: Excessive thirst, a common symptom of uncontrolled diabetes due to dehydration from osmotic diuresis.
Polyphagia: Excessive hunger signaling the body’s inability to utilize glucose properly for energy.
Polyuria: Increased urination frequently resulting from high blood sugar levels leading to osmotic diuresis.
Prediabetes: A condition of elevated blood glucose that is not high enough to be classified as diabetes, often a precursor to type 2 diabetes and indicative of insulin resistance.
Type I diabetes mellitus: An autoimmune disorder leading to significant insulin deficiency, usually diagnosed in children and adolescents, necessitating lifelong insulin therapy.
Type 2 diabetes mellitus: More commonly diagnosed in adults, this form involves insulin resistance and is frequently associated with obesity and sedentary lifestyle, often managed with lifestyle modifications and oral medications.
Drug Profiles
Acarbose (p. 505): An alpha-glucosidase inhibitor that delays carbohydrate absorption in the intestine, useful in postprandial glucose control.
Glipizide (p. 505): A sulfonylurea that stimulates insulin release from pancreatic beta cells, indicated for type 2 diabetes.
Liraglutide (p. 507): A GLP-1 receptor agonist that enhances glucose-dependent insulin secretion, promotes satiety and slow gastric emptying.
Metformin (p. 505): An antihyperglycemic agent that decreases hepatic glucose production and improves insulin sensitivity, considered a first-line treatment for type 2 diabetes.
Pioglitazone (p. 505): A thiazolidinedione that increases insulin sensitivity in peripheral tissues, particularly muscle and fat.
Repaglinide (p. 505): An oral hypoglycemic agent that stimulates rapid insulin release from the pancreas, indicated for type 2 diabetes.
Sitagliptin (p. 505): A DPP-4 inhibitor that increases incretin levels, thereby enhancing insulin secretion and suppressing glucagon release post-meal.
High-Alert Drugs
Insulin glargine and insulin detemir (p. 500): Long-acting insulins that provide a steady release of insulin, helping maintain glucose control with less risk of hypoglycemia.
Insulin isophane suspension (NPH) (p. 500): An intermediate-acting insulin used broadly in diabetes management.
Insulin lispro (p. 500): A rapid-acting insulin designed for quick absorption to manage postprandial hyperglycemia.
Regular insulin (p. 500): A short-acting insulin often used in acute settings to control blood glucose levels.
Pancreas Functions
The pancreas is a vital organ located behind the stomach acting both as an exocrine gland (producing digestive enzymes like lipase, amylase, proteases) and an endocrine gland (producing hormones like insulin and glucagon).
Major hormones include insulin (from beta cells, facilitating glucose uptake) and glucagon (from alpha cells, prompting glycogen breakdown).
Glucose serves as the primary energy source, being stored as glycogen in the liver and muscle tissue.
Glycogenolysis is stimulated by glucagon to mobilize glucose during fasting states when blood sugar decreases.
Insulin performs several critical roles, including promoting the uptake of glucose into tissues, converting excess glucose to glycogen, and inhibiting hepatic glucose production.
The absence of insulin leads to hyperglycemia and subsequent ketone production, triggering symptoms such as polyphagia, weight loss, polydipsia, and polyuria, critical to recognize in disease progression.
Insulin also plays a role in lipid metabolism, promoting lipogenesis while inhibiting lipolysis, and aids in potassium and magnesium balance by facilitating their uptake into cells, thus reducing serum levels.
Pathophysiology of Diabetes Mellitus
Hyperglycemia emerges from a disrupted balance between insulin and glucagon, resulting in elevated blood glucose levels associated with acute and chronic complications.
Diagnostic criteria established by the American Diabetes Association (ADA) include:
Fasting plasma glucose ≥126 mg/dL
A1C ≥6.5%
Any symptoms of diabetes accompanied by casual plasma glucose ≥200 mg/dL
Oral glucose tolerance test ≥200 mg/dL
Multiple factors contribute to diabetes pathophysiology, including impaired insulin production and insulin resistance, with complications arising from sustained hyperglycemia, creating both macrovascular and microvascular risks.
Macrovascular complications: These complications include atherosclerotic changes leading to conditions like coronary artery disease, stroke, and peripheral vascular disease.
Microvascular complications: These include damage to capillary vessels leading to conditions such as retinopathy (vision impairment), nephropathy (kidney disease), and neuropathy (nerve damage), which can contribute to diabetic foot ulcers and increase morbidity.
Types of Diabetes Mellitus
Type 1 Diabetes Mellitus
This chronic autoimmune disorder primarily affects the pancreas's ability to produce insulin, with symptoms often presenting in childhood or adolescence. Rapid onset is common, necessitating various forms of insulin therapy to manage blood glucose.
Represents ≤10% of total diabetes cases and is often characterized as brittle diabetes, indicating difficulty in achieving stable glucose levels.
Type 2 Diabetes Mellitus
Type 2 diabetes is more prevalent, accounting for about 90% of cases, often originating from insulin resistance. Initial stages can exhibit normal to elevated insulin levels despite increased blood glucose, commonly triggered by obesity and sedentary lifestyles.
Gestational Diabetes
This form of diabetes arises during pregnancy, frequently managed with dietary modifications, but may require insulin therapy to mitigate risks for both mother and child. It's essential for the long-term health of the mother and child as it increases the risk of developing type 2 diabetes.
Complications of Diabetes
Long-term diabetes complications include issues such as diabetic retinopathy, neuropathy, nephropathy, cardiovascular diseases, and hypertension, highlighting the importance of regular monitoring of A1C levels and fasting blood glucose to manage diabetes effectively.
Acute Diabetic Complications
Diabetic Ketoacidosis (DKA)
This condition represents a complex metabolic derangement characterized by extreme hyperglycemia, the presence of ketones, and acidemia, often precipitated by stressors like infection or omission of insulin therapy.
Hyperosmolar Hyperglycemic Syndrome (HHS)
HHS is a severe complication typically associated with type 2 diabetes, characterized by hyperglycemia and dehydration, leading to high mortality rates, which does not usually present with significant ketosis.
Non-Pharmacologic Treatments
Essential lifestyle modifications, such as dietary changes and regular exercise, are crucial to achieving effective symptomatic control and improving metabolic health in diabetes management.
Nursing Considerations
A comprehensive nursing assessment related to diabetes and its drug therapies should include monitoring blood glucose levels and evaluating medication regimens tailored to individual patient needs, emphasizing the importance of patient education and engagement in self-care practices.